With the abuse of opioids on the rise in the United States, Stanford University researchers are concerned that increased HIV transmission from shared needles won't be far behind.
Researchers from the University of Copenhagen have developed a strategy that can revolutionize vaccine design. The new strategy is used to develop vaccines that can prevent HIV infection and the development of AIDS.
ECDC has published a rapid risk assessment to assess the risk of outbreaks and transmission of communicable diseases during the WorldPride festival period taking place in Madrid in June 2017. For respiratory and vector-borne diseases, the risk is considered low, for food and waterborne diseases the risk is low to moderate, for vaccine-preventable diseases, it is moderate and for sexually transmitted infections, the risk is moderate to high.
A new report from the National Academies of Sciences, Engineering, and Medicine identifies global health priorities in light of current and emerging challenges and makes 14 recommendations for the US government and other stakeholders to address these challenges, while maintaining US status as a world leader in global health.
A special issue of the Journal of Infectious Diseases focuses solely on HIV eradication and is edited by the director of the UNC HIV Cure Center in Chapel Hill.
Researchers have discovered a mechanism by which the body's immune reaction to viruses like influenza and HIV may cause learning and memory problems.
Using prevention surveillance data to model rates of HIV incidence, prevalence and mortality, investigators at Brigham and Women's Hospital and Johns Hopkins Bloomberg School of Public Health set targets, specifically a decrease in new infections to 21,000 by 2020 and to 12,000 by 2025, that would mark a transition toward ending the HIV/AIDS epidemic.
From diagnosis of HIV to successful viral suppression: this new ECDC report summarizes key findings concerning and the Continuum of HIV Care in Europe based on data reported by countries in Europe and Central Asia. In the 37 countries reporting data, an estimated 1.2 million people are living with HIV, 898 000 of whom (75 percent) have been diagnosed. 88 percent of these are estimated to be virally suppressed.
Scientists at the Gladstone Institutes discovered that an enzyme called SMYD2 could be a new therapeutic target for flushing out the HIV that hides in infected individuals. Overcoming this latent virus remains the most significant obstacle to a cure.
Mothers in the early phases of HIV infection who continued antiretroviral therapy (ART) postpartum experienced a significantly slower rate of disease progression than those who stopped using ART after delivery, according to a study published May 10, 2017, in the open-access journal PLOS ONE by Judith S. Currier of the University of California, Los Angeles, and colleagues from the International Maternal Pediatric and Adolescent and Adult AIDS Clinical Trials Networks.